Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-066982
Filing Date
2025-05-08
Accepted
2025-05-08 16:14:38
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q crnx-20250331.htm   iXBRL 10-Q 1964343
2 EX-10.2 crnx-ex10_2.htm EX-10.2 241153
3 EX-31.1 crnx-ex31_1.htm EX-31.1 32337
4 EX-31.2 crnx-ex31_2.htm EX-31.2 32285
5 EX-32.1 crnx-ex32_1.htm EX-32.1 10569
  Complete submission text file 0000950170-25-066982.txt   9590517

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20250331.xsd EX-101.SCH 1267732
70 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20250331_htm.xml XML 1892229
Mailing Address 6055 LUSK BLVD. SAN DIEGO CA 92121
Business Address 6055 LUSK BLVD. SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38583 | Film No.: 25926283
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)